NASDAQ:BKYI - BIO-key International Stock Price Target and Predictions

  • Consensus Rating: N/A
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00 %
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$2.03
▲ +0.03 (1.50%)

This chart shows the closing price for BKYI by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New BIO-key International Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for BKYI and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for BKYI

Analyst Price Target is $0.00
▼ -100.00% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for BIO-key International in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $2.03.

This chart shows the closing price for BKYI for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is N/A

The current consensus among 0 investment analysts is to n/a stock in BIO-key International. This rating has held steady since March 2022, when it changed from a Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
2/14/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
5/15/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
8/13/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
11/11/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
2/9/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
5/10/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/9/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
8/8/2022

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
3/26/2021Maxim GroupUpgradeHold ➝ Buy$6.00High
8/11/2020Maxim GroupReiterated RatingHoldHigh
10/4/2019Maxim GroupDowngradeBuy ➝ HoldLow
8/30/2019Maxim GroupSet Price TargetBuy$2.00Low
7/29/2019Maxim GroupReiterated RatingBuy$2.25Low
4/2/2019Maxim GroupReiterated RatingBuy$4.00Low
11/15/2018Maxim GroupReiterated RatingBuy$4.00Medium
8/16/2018Maxim GroupLower Price TargetBuy ➝ Buy$5.50 ➝ $5.00Low
4/24/2018Maxim GroupInitiated CoverageBuy ➝ Buy$5.50Medium
3/29/2018Maxim GroupSet Price TargetBuy$6.00High
12/21/2017Maxim GroupReiterated RatingBuy$5.50Low
(Data available from 8/9/2017 forward)

News Sentiment Rating

1.32 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 2 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
1/11/2022
  • 5 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
2/10/2022
  • 5 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
3/12/2022
  • 4 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
4/11/2022
  • 6 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
5/11/2022
  • 2 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
6/10/2022
  • 2 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
7/10/2022
  • 3 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
8/9/2022

Current Sentiment

  • 3 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
BIO-key International logo
BIO-key International, Inc. develops and markets fingerprint identification biometric technology and software solutions, and enterprise-ready identity access management solutions for commercial, government, and education customers in the United States and internationally. The company offers BIO-key PortalGuard and PortalGuard IDaaS solutions, a customer-controlled and neutral-by-design cloud-based identity platform that allows customers to integrate with any cloud or on-premises SaaS application, as well as windows device authentication through IAM platform. Its solutions enable its customers to secure their workforces and student populations; and make their partner networks more collaborative. In addition, it provides BIO-key VST and WEB-key products; and Civil and Large-Scale ID Infrastructure solutions that develops finger-based biometric technology. Further, it offers finger scanners for enterprise and consumer markets under SideSwipe, EcoID, and SidePass brand names. The company was formerly known as SAC Technologies and changed its name to BIO-key International, Inc. in 2002. BIO-key International, Inc. was founded in 1993 and is headquartered in Wall, New Jersey.
Read More

Today's Range

Now: $2.03
Low: $1.96
High: $2.05

50 Day Range

MA: $1.79
Low: $1.62
High: $2.03

52 Week Range

Now: $2.03
Low: $1.59
High: $3.80

Volume

20,103 shs

Average Volume

9,623 shs

Market Capitalization

$17.09 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.8

Frequently Asked Questions

What sell-side analysts currently cover shares of BIO-key International?

The following Wall Street sell-side analysts have issued reports on BIO-key International in the last twelve months:
View the latest analyst ratings for BKYI.

What is the current price target for BIO-key International?

0 Wall Street analysts have set twelve-month price targets for BIO-key International in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for BIO-key International in the next year.
View the latest price targets for BKYI.

What is the current consensus analyst rating for BIO-key International?

BIO-key International currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for BKYI.

What other companies compete with BIO-key International?

How do I contact BIO-key International's investor relations team?

BIO-key International's physical mailing address is 3349 HIGHWAY 138 BUILDING A SUITE E, WALL NJ, 07719. The technology company's listed phone number is (732) 359-1100 and its investor relations email address is [email protected] The official website for BIO-key International is www.bio-key.com. Learn More about contacing BIO-key International investor relations.